An Acupuncture Study for People At High Risk for Sepsis - Trial NCT06344819
Access comprehensive clinical trial information for NCT06344819 through Pure Global AI's free database. This Phase 2 trial is sponsored by Memorial Sloan Kettering Cancer Center and is currently Recruiting. The study focuses on Sepsis. Target enrollment is 78 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Memorial Sloan Kettering Cancer Center
Timeline & Enrollment
Phase 2
Mar 20, 2024
Mar 20, 2028
Primary Outcome
Number of participants recruited compared to the number of participants who complete study treatment.
Summary
Researchers think acupuncture may improve outcomes for participants with sepsis, based on
 laboratory studies and previous studies in people with sepsis. The purpose of this study to
 see whether real acupuncture can improve outcomes for participants with sepsis when compared
 to sham acupuncture. Sham acupuncture is performed the same way as real acupuncture but will
 use different needles and target different sites or places on the body than real acupuncture.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06344819
Non-Device Trial